Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 9 Recruiting 4 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 41 INDUSTRY 25 NIH 5 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Stomach Neoplasms 8 Prostatic Neoplasms 6 Ovarian Neoplasms 5 Neoplasms 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Lymphoma, Follicular 2 Fallopian Tube Neoplasms 2 COVID-19 2 Breast Cancer Lymphedema 2 Anxiety Disorders 2 Adenoma 2 Uveitis 1 Uterine Cervical Dysplasia 1 Stress, Psychological 1 Stomatitis 1 Skin Neoplasms 1 Scleritis 1 Renal Insufficiency, Chronic 1 Radiation Injuries 1 Pulmonary Disease, Chronic Obstructive 1 Progression-Free Survival 1 Ovarian, Fallopian, and Primary Peritoneal Cancer 1 Operable Breast Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER_GOV × Lymphoma, B-Cell × Clear all

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡